2022
20th anniversary
2021
VLP purification patent granted in EU and US
2019
acquisition of SplitCore technology
2018
15 L pilot scale facility established
2017
new VLP patent granted in EU
2016
collaboration with BioSun on development of a Gardasil-like HPV vaccine
2015
first collaborations in the veterinary vaccine field
2014
SUN Global FZE as strategic investor
2013
bio-similar tech transfers to Vietnam, Thailand and Indonesia
2012
first collaborations in the area VLP based vaccines
2011
first bio-similar technology transfers & establishment of secretory E. coli platform
2010
acquisition of the patent family „VLP vaccines“
2008
establishment of process development group, second chaperone patent
2007
move in facility in Langenfeld (850 sqm labs and offices)
2006
first patent granted (chaperone)
2002
foundation as contract R&D company and first license deals